InsidersTradesSigma
Total declarations
Companies
▲ Purchases (4 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
4
Disclosed sells
0
T+90 hit rate
33%
T+90 mean return
+45.5%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by USMAN NASSIM, Chairman & CEO. Insider active across 2 companies, notably Catalyst Biosciences, INC.. Aggregated, 9 filings have been recorded. Breakdown: 4 buys · 0 sell. Total volume traded: €8k. History available since 9 August 2021. The latest transaction was filed on 28 June 2024 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Declarations9 total
3,452 shares@ US$6.935.5% of flowCommon StockSEC:0001140361-24-032024:0
20,000 shares@ US$6.9331.7% of flowCommon StockSEC:0001140361-24-024125:0
20,000 shares@ US$6.9331.6% of flowCommon StockSEC:0001140361-24-017566:0
20,000 shares@ US$6.9331.2% of flowCommon StockSEC:0001140361-24-014164:0
24.541 sharesSeries Y Preferred StockSEC:0001140361-23-042367:0
3,250 shares@ US$0.4718.4% of flowCommon StockSEC:0001209191-22-045256:0
Canonical exit: 7 Nov 2022 (T+90)
3,250 shares@ US$0.460.0002% mcap19.7% of flowCommon StockSEC:0001209191-22-010407:0
Canonical exit: 10 May 2022 (T+90)
867 shares@ US$3.620.0005% mcap40.2% of flowCommon StockSEC:0001209191-21-050759:0
Canonical exit: 7 Nov 2021 (T+90)
867 shares@ US$3.6232.8% of flowCommon StockSEC:0001209191-21-050759
Canonical exit: 7 Nov 2021 (T+90)
9 of 9 declarations
About USMAN NASSIM
Nassim Usman is the President & CEO of CATALYST BIOSCIENCES, INC. He is responsible for the overall leadership of the company, including strategy, operations, and resource management. With a strong background in the biopharmaceutical sector, he guides the company in developing innovative solutions. His leadership is essential for achieving the organization's growth and profitability objectives.
